We are live on ! Find out more
TECX

Tectonic Therapeutic

99 hedge funds and large institutions have $166M invested in Tectonic Therapeutic in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 27

19% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 16

2% more funds holding

Funds holding: 9799 (+2)

0.76% less ownership

Funds ownership: 6.46%5.7% (-0.76%)

42% less capital invested

Capital invested by funds: $287M → $166M (-$122M)

43% less call options, than puts

Call options by funds: $35K | Put options by funds: $61K

Holders
99
Holders Change
+2
Holders Change %
+2.06%
% of All Funds
1.73%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
34
Reduced
27
Closed
16
Calls
$35K
Puts
$61K
Net Calls
-$26K
Net Calls Change
-$147K

TECX Hedge Fund Activity: Q3 2021 in Review

99 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q3 2021, worth a combined $166M — down 42% from $287M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new TECX positions and 16 closed out — a net gain of 3 holders — while 34 added to existing stakes and 27 trimmed.

The largest buyer was MPM BioImpact, opening a new position worth an estimated $5.89M. The largest seller was State Street, cutting an estimated $12.8M.

  • 99 institutional investors held Tectonic Therapeutic (TECX) as of Q3 2021, up from 97 in Q2 2021.
  • Funds reported $166M of Tectonic Therapeutic stock for Q3 2021, down 42% quarter-over-quarter.
  • 19 funds opened new Tectonic Therapeutic positions in Q3 2021 and 16 closed out, a net change of +3 holders.
  • The largest Tectonic Therapeutic buyer in Q3 2021 was MPM BioImpact, an estimated $5.89M added.
  • The largest Tectonic Therapeutic seller in Q3 2021 was State Street, an estimated $12.8M sold.

Based on aggregated 13F filings for Q3 2021.